F033 Unraveling Frontal Fibrosing Alopecia: Current Landscape and Challenges
DESCRIPTION
Frontal fibrosing alopecia (FFA) is a relatively newly described disease which is now commonly seen in medical dermatology and hair disease clinics. This session will review the current landscape of what we know about frontal fibrosing alopecia. Treatment algorithms for patients with newly diagnosed and those with extensive burnt out disease will be discussed. The session will conclude with the introduction of new technologies to treat and monitor patients as well as tools to address patient expectations.
LEARNING OBJECTIVES
Describe and implement treatments for FFA.
Apply new technologies to assess and monitor therapeutic outcomes.
Summarize current research in FFA.
SCHEDULE
3:30 PM
Introduction
Maria K. Hordinsky, MD, FAAD
3:33 PM
Pathogenesis – present, past and future
Maria K. Hordinsky, MD, FAAD
3:45 PM
Update on the clinical diagnosis and scoring systems
Isabella Doche, MD, PhD, IFAAD
3:57 PM
Update on treatment
Sergio Vano-Galvan, MD, PhD, IFAAD
4:09 PM
FFA registry and clinical research
Elise A. Olsen, MD, FAAD
4:21 PM
Q & A and Clinical cases
Isabella Doche, MD, PhD, IFAAD, Antonella Tosti, MD, Sergio Vano-Galvan, MD, PhD, IFAAD
4:36 PM
Sunscreens and FFA – what should we be telling our patients?
Henry W. Lim, MD, FAAD
4:48 PM
Cosmetics and FFA – approach to managing facial papules and hyperpigmentation
Ronda S. Farah, MD, FAAD
5:00 PM
Patch tests and allergies in FFA
Maryanne Makredes Senna, MD, FAAD
5:12 PM
Scarring Alopecia Foundation
Jean Pickford
5:17 PM
Q &A and Treatment controversies
5:27 PM
Closing
Maria K. Hordinsky, MD, FAAD
DIRECTOR
Maria K. Hordinsky, MD, FAAD
CO-DIRECTOR
Isabella Doche, MD, PhD, IFAAD
SPEAKERS
Ronda S. Farah, MD, FAAD
Henry W. Lim, MD, FAAD
Maryanne Makredes Senna, MD, FAAD
Elise A. Olsen, MD, FAAD
Jean Pickford
Antonella Tosti, MD
Sergio Vano-Galvan, MD, PhD, IFAAD
HANDOUTS
DISCLOSURES
Isabella Doche, MD, PhD, IFAAD
Ache Laboratório Farmaceuticso S.A. – Speaker/Faculty Education(Fees); Cantabria Labs – Speaker/Faculty Education(Fees); Fotofinder – Other(Equipment); GlaxoSmithKline Immunology – Speaker/Faculty Education(Fees); L'Oreal – Speaker/Faculty Education(Fees); Mantecorp – Consultant (1099 relationship)(Fees); Panalab – Speaker/Faculty Education(Fees); Pfizer Inc. – Advisory Board(Fees), Speaker/Faculty Education(Fees); Pierre Fabre – Speaker/Faculty Education(Fees); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria); TheraSkin Farmacêutica – Consultant (1099 relationship)(Fees);
Ronda S. Farah, MD, FAAD
American Academy of Dermatology – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Early Sullivan Wright Gizer & McRae LLP – Consultant (1099 relationship)(Fees); Eli Lilly – Investigator(Grants/Research Funding); Incyte – Investigator(Grants/Research Funding); Intrepid Therapeutics, Inc. – Investigator(Grants/Research Funding); Lumenis Be Ltd. – Consultant (1099 relationship)(Fees); Novartis – Advisory Board(Fees); Pfizer – Investigator(Grants/Research Funding); Pfizer Inc. – Stockholder(No Compensation Received), Stockholder Public Company(No Compensation Received); Sun Pharma Advanced Research Company (SPARC) – Advisory Board(Honoraria); Technoderma Medicines – Investigator(Grants/Research Funding); Veradermics – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Maria K. Hordinsky, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Almirall – Other(Fees); CeraVe – Advisory Board(Honoraria); Cosmo Pharmaceuticals Inc. – Other(Other Financial Benefit); Eli Lilly and Company – Investigator(Grants/Research Funding); McGraw-Hill Companies – Other(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Priovant – Investigator(Grants/Research Funding); Sun Pharmaceuticals – Investigator(Grants/Research Funding); UpToDate, Inc – Other(Fees); VeraDermics Inc. – Investigator(Grants/Research Funding);
Henry W. Lim, MD, FAAD
Boehringer Ingelheim – Advisory Board(Honoraria); Cantabria Labs – Consultant (1099 relationship)(Honoraria); Clinuvel – Speaker(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); ISDIN – Consultant(Fees), Speaker(Honoraria); Kenvue – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); La Roche-Posay – Investigator(Grants/Research Funding); La Roche-Posay Laboratoire Pharmaceutique – Speaker/Faculty Education(Fees); NAOS (Aix-En-Provence, France) – Consultant (1099 relationship)(Honoraria); Patient-Centered Outcomes Research Institute – Investigator(Grants/Research Funding); PCORI – Investigator(Fees); Rxilient – Speaker(Fees);
Maryanne Makredes Senna, MD, FAAD
AbbVie – Advisory Board(Fees); American Hair Research Society – Board of Directors(No Compensation Received); Cicatricial Alopecia Research Foundation – Board of Directors(No Compensation Received); CoreEvitas, LLC – Advisory Board(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Fees); GLife – Advisory Board(Stock Options); Inmagene – Investigator(Grants/Research Funding); Inmagene Biopharmaceuticals – Consultant (1099 relationship)(Fees); Kintor Pharmaceutical Limited – Consultant (1099 relationship)(Fees); L'Oreal USA Inc. – Consultant (1099 relationship)(Fees); Leo Pharma Inc – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Fees), Speaker(Fees); Priovant Therapeutics – Advisory Board(Fees), Investigator(Grants/Research Funding); Q32 Bio Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Advisory Board(Fees); Veradermics – Advisory Board(Fees), Advisory Board(Stock);
Elise A. Olsen, MD, FAAD
Absci – Advisory Board(Honoraria); Aranda Pharm Ltd – Consultant (1099 relationship)(Honoraria); Canfield Scientific, Inc. – Consultant(Honoraria); Cosmos – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Taisho Pharmaceuticals Co., Ltd. – Consultant (1099 relationship)(Honoraria); United States Cutaneous Lymphoma Consortium – Other(Grants/Research Funding); UpToDate, Inc – Other(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Jean Pickford
No financial relationships exist with ineligible companies.
Antonella Tosti, MD
Almirall – Advisory Board(Fees); Amgen – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Concert Pharmaceuticals – Investigator(Salary); DS Laboratories – Consultant(Fees); Eli Lilly and Company – Consultant(Honoraria), Investigator(Salary); L'Oreal USA Inc. – Advisory Board(Honoraria); Myovant Sciences – Advisory Board(Fees); Ortho Dermatologics – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Honoraria); Springer Science & Business Media – Other(Patent royalties or other compensation for Intellectual Property Rights); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); Taylor & Francis – Other(Patent royalties or other compensation for Intellectual Property Rights); The WellBeauty Company, LLC – Consultant (1099 relationship)(Fees); Thirty Madison, Inc. – Consultant(Honoraria); VeraDermics Inc. – Advisory Board(Honoraria);
Sergio Vano-Galvan, MD, PhD, IFAAD
AbbVie – Speaker(Fees); Cantabria Labs – Advisory Board(Fees); Fotofinder – Speaker(Fees); L'Oréal France – Advisory Board(Fees); Lilly ICOS LLC – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Fees);